What does NORD EXPLOITATION OPHTALMOLOGIQUE do?

NORD EXPLOITATION OPHTALMOLOGIQUE is a rental company in Etterbeek. Private Limited, started on 2 November 2009, 1 establishment.

What is the address of NORD EXPLOITATION OPHTALMOLOGIQUE?

The registered office of NORD EXPLOITATION OPHTALMOLOGIQUE is located at Aduatukersstraat 103, 1040 Etterbeek.

Is NORD EXPLOITATION OPHTALMOLOGIQUE still active?

Yes. According to the CBE (17 September 2026) NORD EXPLOITATION OPHTALMOLOGIQUE is active, legal situation “Normale toestand”, started on 2 November 2009.

Is NORD EXPLOITATION OPHTALMOLOGIQUE registered on Peppol?

Yes, NORD EXPLOITATION OPHTALMOLOGIQUE is registered on the Peppol network with ID 0208:0820238037.

What is the enterprise number of NORD EXPLOITATION OPHTALMOLOGIQUE?

The enterprise number of NORD EXPLOITATION OPHTALMOLOGIQUE is BE0820238037.

When was NORD EXPLOITATION OPHTALMOLOGIQUE founded?

NORD EXPLOITATION OPHTALMOLOGIQUE was founded on 2 November 2009.

Who are the directors of NORD EXPLOITATION OPHTALMOLOGIQUE?

According to the 2025 annual accounts, the directors of NORD EXPLOITATION OPHTALMOLOGIQUE are: Dinu Stanescu.

Is NORD EXPLOITATION OPHTALMOLOGIQUE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 November 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NORD EXPLOITATION OPHTALMOLOGIQUE make in 2025?

NORD EXPLOITATION OPHTALMOLOGIQUE recorded a loss after taxes of € 84,755 in financial year 2025.

What is the revenue of NORD EXPLOITATION OPHTALMOLOGIQUE?

As a small company, NORD EXPLOITATION OPHTALMOLOGIQUE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 126,043.

NORD EXPLOITATION OPHTALMOLOGIQUE (Private Limited)

Dossier NORD EXPLOITATION OPHTALMOLOGIQUE, printed on 17 September 2026 from databakkes.be/en/0820238037/nord-exploitation-ophtalmologique. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 29 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

NORD EXPLOITATION OPHTALMOLOGIQUE from Etterbeek, company number BE0820238037, closed financial year 2025 with a result of € -84,755 after tax. For that financial year NORD EXPLOITATION OPHTALMOLOGIQUE recorded a gross margin of € 126,043 and equity of € 150,695. Compared with financial year 2024, the result moved from € -73,699 to € -84,755. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 150,695

▼ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -84,755

▼ 15 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,803

▼ 73% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 138,295.

People and assets in 2025

Wage cost

€ 16,287

▼ 5% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 37,547

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.3 million

▼ 2% vs 2024

€ 83,903 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 3,928

▼ 86% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 935

▼ 99% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,548 Gross margin 2022: € 2,548 First fiscal year in the series	€ 555,401 Gross margin 2023: € 555,401 ▲ € 552,853 vs 2022 (€ 2,548) Favourable step	€ 117,785 Gross margin 2024: € 117,785 ▼ 79% vs 2023 (€ 555,401) Unfavourable step	€ 126,043 Gross margin 2025: € 126,043 ▲ 7% vs 2024 (€ 117,785) Favourable step	▲ 7%
Profit after taxes	€ -2,781 Profit after taxes 2022: € -2,781 First fiscal year in the series	€ 318,194 Profit after taxes 2023: € 318,194 ▲ € 320,975 vs 2022 (€ -2,781) Favourable step	€ -73,699 Profit after taxes 2024: € -73,699 ▼ € 391,893 vs 2023 (€ 318,194) Unfavourable step	€ -84,755 Profit after taxes 2025: € -84,755 ▼ € 11,056 vs 2024 (€ -73,699) Unfavourable step	▼ € 11,056
Equity	€ -9,045 Equity 2022: € -9,045 First fiscal year in the series	€ 309,149 Equity 2023: € 309,149 ▲ € 318,194 vs 2022 (€ -9,045) Favourable step	€ 235,450 Equity 2024: € 235,450 ▼ 24% vs 2023 (€ 309,149) Unfavourable step	€ 150,695 Equity 2025: € 150,695 ▼ 36% vs 2024 (€ 235,450) Unfavourable step	▼ 36%
Total debts	€ 999,132 Total debts 2022: € 999,132 First fiscal year in the series	€ 2,058,298 Total debts 2023: € 2,058,298 ▲ 106% vs 2022 (€ 999,132) Unfavourable step	€ 2,464,252 Total debts 2024: € 2,464,252 ▲ 20% vs 2023 (€ 2,058,298) Unfavourable step	€ 2,480,938 Total debts 2025: € 2,480,938 ▲ 1% vs 2024 (€ 2,464,252) Unfavourable step	▲ 1%
Cash	€ 317,768 Cash 2022: € 317,768 First fiscal year in the series	€ 109,369 Cash 2023: € 109,369 ▼ 66% vs 2022 (€ 317,768) Unfavourable step	€ 103,640 Cash 2024: € 103,640 ▼ 5% vs 2023 (€ 109,369) Unfavourable step	€ 27,803 Cash 2025: € 27,803 ▼ 73% vs 2024 (€ 103,640) Unfavourable step	▼ 73%
Land & buildings	€ 67,010 Land & buildings 2022: € 67,010 First fiscal year in the series	€ 1,070,467 Land & buildings 2023: € 1,070,467 ▲ € 1 million vs 2022 (€ 67,010) Unchanged	€ 1,221,202 Land & buildings 2024: € 1,221,202 ▲ 14% vs 2023 (€ 1,070,467) Unchanged	€ 1,202,614 Land & buildings 2025: € 1,202,614 ▼ 2% vs 2024 (€ 1,221,202) Unchanged	▼ 2%
Retained profit	€ -21,445 Retained profit 2022: € -21,445 First fiscal year in the series	€ 296,749 Retained profit 2023: € 296,749 ▲ € 318,194 vs 2022 (€ -21,445) Favourable step	€ 223,050 Retained profit 2024: € 223,050 ▼ 25% vs 2023 (€ 296,749) Unfavourable step	€ 138,295 Retained profit 2025: € 138,295 ▼ 38% vs 2024 (€ 223,050) Unfavourable step	▼ 38%
Bank debt	€ 65,440 Bank debt 2022: € 65,440 First fiscal year in the series	€ 1,241,900 Bank debt 2023: € 1,241,900 ▲ € 1.2 million vs 2022 (€ 65,440) Unfavourable step	€ 1,308,521 Bank debt 2024: € 1,308,521 ▲ 5% vs 2023 (€ 1,241,900) Unfavourable step	€ 1,275,842 Bank debt 2025: € 1,275,842 ▼ 2% vs 2024 (€ 1,308,521) Favourable step	▼ 2%
Balance sheet total	€ 990,088 Balance sheet total 2022: € 990,088 First fiscal year in the series	€ 2,367,447 Balance sheet total 2023: € 2,367,447 ▲ 139% vs 2022 (€ 990,088) Unchanged	€ 2,699,702 Balance sheet total 2024: € 2,699,702 ▲ 14% vs 2023 (€ 2,367,447) Unchanged	€ 2,631,633 Balance sheet total 2025: € 2,631,633 ▼ 3% vs 2024 (€ 2,699,702) Unchanged	▼ 3%

Key figures of NORD EXPLOITATION OPHTALMOLOGIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NORD EXPLOITATION OPHTALMOLOGIQUE?

What happened at NORD EXPLOITATION OPHTALMOLOGIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 84,755. filed late Source: NBB ↗
Mar 7, 2010 New establishment in Etterbeek. KBO
Nov 2, 2009 Start of the company according to the CBE. KBO
2009 Dinu Stanescu became a director. NBB

In short

From € 2,781 loss in 2022 to € 84,755 loss in 2025.

Paid € 122,137 in corporate taxes since 2022.

Best year ever: 2023, with € 318,194 profit.

Original PDFs at the National Bank ↗

A new publication or filing at NORD EXPLOITATION OPHTALMOLOGIQUE? We notify you, reason included.

Follow NORD EXPLOITATION OPHTALMOLOGIQUE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit